NeLM news service
Palonosetron capsules (Aloxi) launched in UK for prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy

Source: EMC

Date published: 18/11/2011 17:26

Summary
by: Hina Radia

IS Pharmaceuticals has launched palonosetron capsules (Aloxi) for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults. The dose is 500 mcg administered approximately one hour before the start of chemotherapy. The cost of a 500 mcg capsule is £55.89.

 

Please see link below to the SPC for full prescribing information.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.